基因编辑

Eli Lilly has inked an exclusive research and licensing deal with Seamless Therapeutics worth up to $1.12 billion to develop programmable recombinase gene-editing therapies for ... 一月 28, 2026

From soil microbes to AI-driven maps, a wave of agritech aims to boost yields, cut emissions and reshape who grows our food. This article maps the technologies, economics and ri... 一月 21, 2026

A new gene‑editing platform called PERT uses engineered suppressor tRNA to bypass premature stop signals in DNA, rescuing protein production in cells and mice and offering a pot... 十二月 05, 2025

A Mammoth Biosciences executive told the Dubai Future Forum that gene editing could treat every genetic disease within ten years. Here’s what the science, recent trials and majo... 十一月 19, 2025